CL
Calumet Specialty Products Partners
CLMT · NASDAQ
$58.12 +0.45% (+$0.26)
1M +22.82%
Market Cap $5.06B
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$52.59
9.5% downside
Current Price
$58.12
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CLMT is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
28 /100
Expensive P/FCF 33.68x
EV/EBITDA 289.72x
P/S 1.10x
Growth
21 /100
Declining Rev. growth 4.07%
Book val. growth N/A
EPS growth N/A
Profitability
20 /100
Weak Op. margin 1.05%
Gross margin 6.57%
FCF margin 3.28%
Quality
29 /100
Poor Asset turnover 1.64x
ROIC 1.50%
ROA 4.88%
Debt
6 /100
High Net debt/EBITDA 86.30x
Current ratio 0.84x
Int. coverage -1.58x
Stability
46 /100
Moderate EPS volatility 381.07%
Beta 0.72x
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CLMT
Online
Sector
Basic Materials
Industry
Chemicals - Specialty
CEO
Louis Todd Borgmann
Employees
1,540
Headquarters
Indianapolis
Upcoming events
06 NOV
Earnings
Upcoming earnings report